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Wolbachia is a genus of Gram-negative intracellular bacteria that is naturally found in more than half of all
arthropod species. These bacteria cannot only reduce the fitness and the reproductive capacities of
arthropod vectors, but also increase their resistance to arthropod-borne viruses (arboviruses). This article
reviews the evidence supporting a Wolbachia-based strategy for controlling the transmission of dengue
and other arboviral infections.
Recent findings
Studies conducted 1 year after the field release of Wolbachia-infected mosquitoes in Australia have
demonstrated the suppression of dengue virus (DENV) replication in and dissemination by mosquitoes.
Recent mathematical models show that this strategy could reduce the transmission of DENV by 70%.
Consequently, the WHO is encouraging countries to boost the development and implementation of
Wolbachia-based prevention strategies against other arboviral infections. However, the evidence regarding
the efficacy of Wolbachia to prevent the transmission of other arboviral infections is still limited to an
experimental framework with conflicting results in some cases. There is a need to demonstrate the efficacy
of such strategies in the field under various climatic conditions, to select the Wolbachia strain that has the
best pathogen interference/spread trade-off, and to continue to build community acceptance.
Summary
Wolbachia represents a promising tool for controlling the transmission of arboviral infections that needs to
be developed further. Long-term environmental monitoring will be necessary for timely detection of potential
changes in Wolbachia/vector/virus interactions.
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Arthropod-borne viruses (arboviruses) are transmit-
ted between vertebrate hosts and blood-feeding
arthropod vectors including mosquitoes, sand flies,
biting midges, mites, lice and ticks [1,2
&
,3]. With the
exception of African swine fever virus, which is a
double-strandedDNAvirus belonging to theAsfarvir-
idae family [4], all other arboviruses have an RNA
genome and belong to one of the following five
families of viruses: Flaviviridae, Togaviridae, Bunyavir-
idae, Rhabdoviridae and Reoviridae [3]. The distri-
bution of arboviruses across the globe is largely
dependent on the distribution of susceptible vector
species, which varies in response to climatic changes.
Their spread is favoured by urbanization, human
travel and livestock movements [1,5,6]. Arboviralrs Kluwer Health, Inc. All rights rese
 Kluwer Health, Inc. Unainfections cause a wide range of life-threatening
manifestations, notably nervous system diseaserved. www.co-infectiousdiseases.com
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KEY POINTS
 Wolbachia is a Gram-negative intracellular bacteria
that is naturally found in more than 50% of all
arthropod species, but is absent in the major arbovirus
vector A. aegypti.
 Wolbachia alters the reproductive fitness of arthropod
vectors through selective male killing, parthenogenesis,
feminization of male embryos and cytoplasmic
incompatibility. It also alters the competence of
transinfected arthropod vectors for the transmission of
arboviruses through competition for resources, immune-
priming, induction of the phenoloxidase cascade and
induction of microRNA-dependent immune pathways.
 Field releases of Wolbachia-transinfected A. aegypti
mosquitoes have been successfully used in the Eliminate
Dengue Programme to suppress the dissemination of
DENV in Australia, but the true epidemiological impact
on dengue-related morbidity and mortality is yet to be
assessed. The evidence regarding the efficacy of
Wolbachia to prevent the transmission of other
arboviruses including chikungunya, JEV, WNV and
Zika is still limited to the experimental framework.
 It is possible that theWolbachia strains that confer the
strongest interference with pathogen transmission do not
spread easily into local vector populations because of
deleterious fitness effects. Adequate selection of
theWolbachia strain is therefore crucial in the
implementation ofWolbachia-based biocontrol strategies.
 There has been some concern about potential exposure
of humans to Wolbachia via mosquito bites. However,
there is currently no evidence that such exposure occurs
(or at least, is medically relevant). In addition, there is
no evidence that the field release of Wolbachia-
infected mosquitoes has any adverse effects on
the environment.
Table 1. Summary of strategies that could be used to prevent the
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Vector Reduce the prevalence of vectors and
their capacity to transmit viruses
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Copyright © 2016 Wolters Kluwer Health, Inc. Unaut(encephalitis, meningitis, seizures, stroke, myelitis,
polyradiculoneuritis and myositis), liver disease
(heptatitis and fulminant hepatic failure) and hae-
morrhagic disease (with thrombocytopenia, coagu-
lopathies, bruisingandbleeding) [2
&
,3,7–10].There is
currently no antiviral treatment for any arboviral
infection; nor have nonspecific treatments like cor-
ticosteroids made a difference [3,11]. Supportive
treatment remains the mainstay and includes the
management of fever, seizures, headaches or raised
intracranialpressure (if any)andmaintenanceofvital
functions. Because of the limited treatment options,
and the wide extent of these diseases, better preven-
tivemeasures are urgently needed. As shown in Table
1 [6,12–17,18
&&
,19–24], these measures could be
implemented at the level of the human host, at the
level of the vector or at the interface between the two.
Preventive measures at the level of the human
host are often not available or prove difficult to
develop. Effective vaccines are only available for
yellow fever virus (YFV) [20], Japanese encephalitis
virus (JEV) [21], dengue [22] and tick-borne encepha-
litis [23]; there is currently none approved for other
widespread arboviruses, notably chikungunya, West
Nile virus (WNV) and Zika [25–27]. Research on
chemoprophylaxis is still in its early stages [24].
Preventivemeasures at the level of the vector include
radiological, chemical and genetic interventions to
eradicate arthropod vectors or limit their reproduc-
tive capacities (the ability to produce viable and
abundant offspring) [13–16]. However, chemical
interventions are limited by the increasing develop-
ment of resistance to insecticides [12], whereas
geneticmodifications raise ecological concerns about
the potential long-term health and environmental
risks [28
&&
,29]. As oneapproach alone is unlikely to betransmission of arboviruses to humans
tegies that could be used
ct killing of vectors by spreading of insecticides [12]
tation of vectors’ reproduction by [13–16]:
troying breeding sites and promoting good sanitary conditions
asing sterile or genetically modified vectors
ducing biological control agents
lbachia-based methods: population replacement with transinfected
ctors displaying reduced vector competence [17,18&&], or
opulation suppression (Incompatible Insect Technique) [19]
of bed nets
of repellents
sitization of travellers and communities at risk
cine [20–23]
moprophylaxis [24]
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Csufficient and/or always affordable, there is an urgent
need for the development of novel strategies for
vector control, prompting a high level of interest
in using the bacterium Wolbachia to control the
transmission of arboviruses.
Wolbachia is a genus of Gram-negative intra-
cellular bacteria belonging to the order Rickettsiales
and the family Anaplasmataceae. These bacteria only
infect invertebrate organisms and are naturally
found in more than 50% of all arthropod species
and in several nematodes [1,30,31]. However, Wol-
bachia is naturally absent from Aedes aegypti (also
called Stegomyia aegypti), but can be introduced
[1,32]. A. aegypti is a widespread human blood-feed-
ing mosquito responsible for the transmission of
several arboviruses including dengue, yellow fever,
Zika, Murray valley, La Crosse, chikungunya and
Rift valley fever viruses. Generally, the different
strains of Wolbachia are named according to the
host in which they were first discovered. For
instance, Wolbachia pipientis (wPip) was the first
strain discovered in the mosquito Culex pipiens
[33]. Similarly, wMel was first isolated from the
common fruit fly Drosophila melanogaster, whereas
wAlb was first isolated from Aedes albopictus [34].
Several studies have demonstrated that Wolbachia
increases arthropods’ resistance to viruses [35–37]
and/or alters their reproductive capacities [17,38].
More recently, researchers of the Eliminate Dengue
Programme in Australia have demonstrated that the
transfer of this bacterium into wild populations of
the mosquito A. aegypti represents an effective
measure to control the transmission of dengue
[18
&&
]. This has led various public health authorities,
including the WHO, to advocate the use of Wolba-
chia-based strategies to control the spread of dengue
and other arthropod-borne viruses [39].
Here, we review the scientific evidence support-
ing the use of Wolbachia-based strategies to control
the transmission of these arboviral infections and
discuss the related risks, challenges and limitations.BENEFICIAL EFFECTS OF WOLBACHIA
FOR CONTROLLING THE TRANSMISSION
OF ARBOVIRAL INFECTIONS
Wolbachia can be used for the control of arboviral
diseases in one of two strategies: the reduction of
vectors’ reproductive capacity and the induction of
resistance to RNA viruses.ALTERATION OF VECTORS’ FITNESS AND
REPRODUCTIVE CAPACITIES
Wolbachia sp. can induce significant alterations of
the reproductive biology of their host including0951-7375 Copyright  2016 Wolters Kluwer Health, Inc. All rights rese
opyright © 2016 Wolters Kluwer Health, Inc. Unaselective male killing, parthenogenesis (a form of
asexual reproduction in which viable embryos
develop from unfertilized eggs), feminization of
genetically male embryos and cytoplasmic incom-
patibility [38]. Cytoplasmic incompatibility refers to
the failure of Wolbachia-infected males to produce
viable offspringwhenmatingwith either uninfected
females or females infected with a different strain of
Wolbachia [40,41]. In the first scenario, the cyto-
plasmic incompatibility is said to be unidirectional
because it will promote the expansion of only one
subpopulation composed of Wolbachia-infected
mosquitoes. In the second scenario, the cytoplasmic
incompatibility may be bidirectional because it can
result in the development of divergent subpopu-
lations, each infected with one of two or more
opposing Wolbachia strains [1,42,43]. However,
infected females canmate successfully with infected
males and this provides them with an evolutionary
advantage over uninfected females [40,41]. The
selective expansion ofWolbachia-infected subpopu-
lations of vectors is responsible for their ability to
invade and progressively replace wild populations
following large-scale field releases [44,45]. Alterna-
tively, if only male infected mosquitoes are released
into an uninfected or incompatible population (the
‘Incompatible Insect Technique’), the vector popu-
lation may crash, which then leaves an ecological
niche for repopulation by noninfected vectors [19].INDUCTION OF VIRAL RESISTANCE IN
ARTHROPOD VECTORS
Wolbachia is thought to induce resistance to arbo-
viruses through four complementary mechanisms
(Fig. 1): competition for resources, preactivation of
the immune system (also referred to as immune-
priming), induction of the phenoloxidase cascade
and induction of microRNA-dependent immune
pathways that are essential for host defence against
viruses [46,47
&&
].Competition for resources
Autophagy is a cellular degradation and recycling
process by which unnecessary or dysfunctional cel-
lular components are incorporated in lysosomes for
digestion. The resulting nutrients aremade available
for further metabolic processes [48]. Wolbachia is
not only able to induce autophagy in arthropod
vector’s cells but also to hijack the autophagy system
in order to ensure its own survival both in vitro and in
vivo [49]. As both flaviviruses and alphaviruses are
dependent on the autophagy pathway to replicate
[50,51], it has been hypothesized that Wolbachia
interferes with the replication of some arbovirusesrved. www.co-infectiousdiseases.com 3
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TRANSINFECTION OF AEDES AEGYPTI WITH WOLBACHIA 
Competition for intracellular 
resources: 
- Induction and hijacking of the autophagy 
system 
- Depletion of iron and cholesterol 
resources necessary for the growth and 
replication of other pathogens 
 
Induction of the 
phenoloxidase 
cascade 
Induction of micro-RNA dependant 
immune pathways (e.g. upregulation 
of aae-miR-2940) 
Immune priming: 
activation of the Toll, Imd 
and JAK-STAT innate 
immune pathways  
Transcriptional upregulation of 
immune genes with increased 
production of antimicrobial 
proteins (e.g. cecropin and 
defensin) 
Upregulation of the 
metalloprotease m41ftsh 
Downregulation of AdDnmt2 (DNA 
cytosine-5-methyltransferase ) 
Increase of  
density in host tissues 
Increased DNA cytosine methylation 
- Increased immune defences 
and genome stability 
- Enhanced regulation of organ 
differentiation and aging 
AUGMENTED RESISTANCE TO ARBOVIRUSES 
Wolbachia
FIGURE 1. Mechanistic pathways of Wolbachia-induced resistance to arboviruses in Aedes aegypti following transinfection
(the plus sign indicates that the increase of Wolbachia density in host tissues aggravates the competition for intracellular
resources).
CNS infections
Copthrough its ability to manipulate the autophagy
system, thus reducing the amount of nutrients avail-
able for viruses.
Wolbachia-mediated antiviral resistance might
also be favoured by competitionwith viruses for iron
and cholesterol. The bacterium is known to manip-
ulate host cell iron reserves, as does the dengue virus
(DENV) and the chikungunya virus (CHIKV)
[52
&
,53]. Like other members of the order Rickett-
siales, Wolbachia is unable to synthesize cholesterol
de novo and therefore relies on host cell cholesterol
reserves for its replication and growth [54]. Sim-
ilarly, mosquito-borne flaviviruses and alphaviruses
have been shown to rely on host cell cholesterol for
cell invasion, replication, virion assembly, infectiv-
ity and release from the infected cells [55–62].Immune-priming
Transinfection of Wolbachia into heterologous
arthropod vectors (i.e. vectors that are not naturally
infected by any, or that specific Wolbachia strain;
such as the mosquito A. aegypti) preactivates their
immune system, enabling it to combat microbes
(including viruses) more effectively. This is done
by inducing three major signalling pathways of
the innate immune system: Toll, Imd (immune
deficiency) and Janus kinase-signal transducer and4 www.co-infectiousdiseases.com
yright © 2016 Wolters Kluwer Health, Inc. Unautactivator of transcription (JAK-STAT) [1,46]. Toll
(from the German adjective ‘toll’ meaning ‘wonder-
ful’) are transmembrane proteins encoded by the
eponymous gene in Drosophila [63]. The JAK-STAT
pathway is made up of one cell surface receptor
called JAK and two proteins acting as STAT [64].
Activation of these signalling pathways leads to the
transcriptional upregulation of antimicrobial pep-
tide genes – such as those that encode drosomycin,
cecropin and defensin – and several other immune
genes [65–68], resulting in increased resistance of
arthropod vectors to various arboviruses [1,69–75].Induction of the phenoloxidase cascade
The phenoloxidase cascade is important in mosqui-
toes’ immune response to viruses [76], andWolbachia
has been recently shown to trigger this pathway both
in homologous and heterologous host vectors [77].Induction of miRNA-dependent immune
pathways
Wolbachia upregulates the microRNA aae-miR-2940
in mosquitoes [78] and this has two consequences:
the upregulation of themetalloproteasem41ftsh and
the downregulation of the DNA cytosine-5-methyl-
transferase gene, AaDnmt2, thus favouring DNAVolume 29  Number 00  Month 2016
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Ccytosine methylation. The latter is indispensable for
host immune defence, gene regulation, genome
stability, organ differentiation and ageing [79].
It is also noteworthy that both the metallopro-
tease m41ftsh and DNA cytosine methylation are
essential for maintaining a high density of Wolba-
chia infection in host cells [78]. Therefore, the upre-
gulation of microRNAs could potentiate the
competition for resources (Fig. 1), as a high density
of Wolbachia creates unfavourable conditions for
viruses by decreasing the amount of available
resources (iron, cholesterol and other lipids) [35,80].APPLICATION OF THE WOLBACHIA-
BASED STRATEGY FOR CONTROLLING
THE TRANSMISSION OF ARBOVIRAL
INFECTIONS: CURRENT RESULTS,
POTENTIAL RISKS AND FUTURE
CHALLENGES
The phenotypic effects of Wolbachia on arthropod
vectors’ reproduction and resistance to viruses make
it a promising tool for controlling the transmission
of arboviral infections. Indeed, Wolbachia has
already been successfully used to control the trans-
mission of dengue, whereas its role in combating
other infections is still being assessed.Initial successes in the Eliminate Dengue
Programme
Dengue is the most important mosquito-borne viral
disease of humans with an estimated 2.5 billion
people at risk in more than 100 countries worldwide,
and 50–100 million infections acquired each year
[81]. It is transmitted principally by the mosquito
A. aegypti, which is present in more than 150
countries and is not naturally infected by Wolbachia
[82
&&
]. The Eliminate Dengue Programme emerged in
2008 from the work of Professor Scott O’Neill and
colleagues [83] (www.eliminatedengue.com). Early
efforts focused on using the life-shortening wMelPop
strain to reduce the number of dengue vectors reach-
ing maturity. This approach took account of the fact
that mature mosquitoes are more likely to transmit
dengue, as the DENVmust incubate in the mosquito
for severaldaysbeforebecoming infectious [83].How-
ever, as transinfection ofA. aegyptiwith thewMelPop
strain induced significant fitness costs [reduction of
the longevity of infected adult females and reduction
in the viability of eggs, whether or not they were in
diapause (i.e. physiological state of dormancy
inducedbyunfavourable environmental conditions)]
[45], there were some concerns about its ability to
rapidly invade wild mosquito populations following
test releases of Wolbachia-infected mosquitoes.0951-7375 Copyright  2016 Wolters Kluwer Health, Inc. All rights rese
opyright © 2016 Wolters Kluwer Health, Inc. UnaIndeed, the greater the fitness costs, the higher the
initial Wolbachia frequencies required for invasion.
According tomathematical predictions, as the fitness
cost of infection approaches 0.5, spatial spreading of
Wolbachia slows tozero [84]. For this reason, research-
ers of the EliminateDengueProgramme turned to the
wMel strain that has a lower fitness cost but still
confers sufficient resistance to DENV [35,37]. In
2011, they reported stable transinfection ofA. aegypti
with wMel [83,85]. They subsequently demonstrated
that this strain reduced the capacity of A. aegypti to
transmit dengue and successfully invaded wild mos-
quito populations [86,87]. This laid the foundations
for the large-scale release ofWolbachia-infected mos-
quitoes in dengue-endemic areas in Australia, result-
ing in successful suppression of DENV replication in
and dissemination by mosquitoes as confirmed by
vector competence experiments carried out 1 year
following field release [18
&&
]. The success of the Elim-
inate Dengue Programme in Australia has led to
further trial releases of Wolbachia-carrying A. aegypti
in other dengue-endemic countries throughout the
world, notably Colombia, Indonesia, Vietnam and
Brazil [82
&&
]. Recentmathematical models have dem-
onstrated that this strategy could reduce the trans-
mission of DENV by 70% [82
&&
,88
&&
]. However, the
true epidemiological impact (reduction of the inci-
dence of dengue and the relative risk of infection
between Wolbachia-treated and untreated areas) of
Wolbachia-based biocontrol strategies for dengue is
yet to be properly assessed through prospective
cohort studies and cluster randomized trials [89
&&
].The potential use of Wolbachia to control
other arboviral infections
Although Wolbachia-infected mosquitoes were
initially generated for the biocontrol of dengue,
there is increasing evidence from experimental stud-
ies that they could also be used to control the
transmission of other arboviruses, notably CHIKV
[90], JEV [91
&
] and YFV [92]. Concerning WNV,
results are more controversial. In 2009, it was
reported for the first time that Wolbachia could
increase resistance toWNV in Culex quinquefasciatus
[80]. However, subsequent reports highlighted the
fact that most C. quinquefasciatus populations are
naturally infected with Wolbachia but are still
capable of transmitting WNV. Moreover, it appears
that transinfection with the wAlbB strain from A.
albopictus enhances WNV infection in Culex tarsalis,
a naturally uninfectedmosquito which is an import-
ant vector ofWNV inNorth America [93
&
]. Finally, it
has been demonstrated recently that Wolbachia-
infectedmosquitoes are highly resistant to infection
with two currently circulating Zika virus isolatesrved. www.co-infectiousdiseases.com 5
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Copfrom the Brazilian epidemic. Wolbachia-infected A.
aegypti also did not carry infectious Zika virus in the
saliva, suggesting that Wolbachia can be used to
block the transmission of Zika fever [94
&&
].Potential risks
Wolbachia-infected mosquitoes are not considered
to be geneticallymodified asWolbachia is a naturally
occurring symbiont of invertebrates. Moreover,
volunteers that are bitten by Wolbachia-infected
mosquitoes do not show any specific antibody pro-
duction against Wolbachia, which probably means
that there is no transmission of the bacteria from
mosquitoes to humans [95]. As Wolbachia is an
obligate intracellular bacterium, it cannot survive
in the environment (air, soil, water and leaves), but
horizontal transmission between arthropods does
occur in nature [96]. Therefore, arthropod predators
of mosquitoes could become infected with Wolba-
chia strains transinfected into their prey. The poten-
tial impact of such stochastic events is difficult to
predict, but considering the ubiquity of Wolbachia
in arthropod populations, deleterious effects on
natural predators seem highly unlikely.Future challenges
Taking into account the initial successes of the
Eliminate Dengue Programme, the WHO currently
encourages affected countries to boost the develop-
ment and implementation ofWolbachia-based mos-
quito control interventions against other arboviral
infections [39]. Nevertheless, before the Wolbachia-
based strategy to control the transmission of arbo-
viral infections can be implemented worldwide,
various issues need to be addressed.
Choosing the optimum Wolbachia strain
Future studies will have to determine which Wol-
bachia strain shows the optimum trade-off between
pathogen interference, the strength of cytoplasmic
incompatibility and other potential fitness effects.
Indeed, it is possible that Wolbachia strains that
confer the strongest interference with pathogen
transmission do not spread easily into local vector
populations because of deleterious fitness effects
[84]. These deleterious fitness effects could take the
form of a reduced lifespan of larval and/or adult
stages [97,98], decreased egg viability [45,99] or
greater susceptibility of Wolbachia-infected mos-
quitoes to some insecticides, and thus should be
carefully monitored. However, the experience to
date with wMel in A. aegypti suggests that this
strain is likely to be well tolerated by other
vector species.6 www.co-infectiousdiseases.com
yright © 2016 Wolters Kluwer Health, Inc. UnautMonitoring evolutionary changes
Evolutionary changes occurring in Wolbachia, the
arboviruses or the arthropod hosts should be moni-
tored over time as they could modulate the efficacy
of the Wolbachia-based prevention strategy [28
&&
].
Furthermore, it is still too early to say to what extent
the Wolbachia-mediated viral resistance in vectors
could trigger the emergence of potentially more
virulent strains of arboviruses.
Obtaining community acceptance
Adequate public engagement is indispensable for the
success of Wolbachia-based mosquito control strat-
egies. Indeed, all public health interventions need to
be well explained in order to be approved by local
regulatory authorities and to ensure the support of
the vast majority of people within the target com-
munities [100]. The lessons learned from the Elim-
inate Dengue Programme should be applied, and
adapted to local conditions, for other arboviral dis-
eases and the respective communities affected.
Accounting for geographical specificities
Wolbachia-based biocontrol strategies might not be
equally efficient or applicable in all geographical
areas. Indeed, in regions endemic for two or more
arboviral diseases with different vectors, the need to
allow spread of a newly released Wolbachia-infected
vector could require that the application of insecti-
cides be halted (at least temporarily), thus allowing
other vectors to thrive, and potentially leading to
increased risks of a disease outbreak. The same con-
cern could arise in areas where a disease is trans-
mitted by two or more vector species. For instance,
dengue and Zika viruses are transmitted byA. aegypti
and A. albopictus, and both species have increased
viral resistance after transinfection with wMel
[17,86]. However, large-scale field releases are cur-
rently restricted to Wolbachia-transinfected A.
aegypti. Moreover, in areas where rare vector species
are more important for disease transmission than
the most widespread ones, Wolbachia-based vector
control strategies might be less cost-effective than
insecticides that target all potential vectors at the
same time. Finally, it is still unclear whether the
results obtained with the Eliminate Dengue Pro-
gramme can be replicated for dengue or other arbo-
viral infections in the tropics, where arthropod
vectors’ density and efficiency are expected to be
higher because of higher temperatures [101].CONCLUSION
The naturally occurring endosymbiont Wolbachia
has several effects on reproduction and vectorVolume 29  Number 00  Month 2016
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Ccompetence in arthropod vectors and therefore
represents a promising tool for controlling the trans-
mission of arboviral infections with apparently
almost no health or environmental risk. Indeed,
mass releases of Wolbachia-transinfected A. aegypti
have already been used successfully in Australia to
block the transmission of DENV with no known
adverse effects. However, more research is required
before the same strategy could be used for other
infections. Indeed, it needs to be confirmed if the
wMel strain is the optimum one, in terms of both
pathogen interference and rate of spread, for other
vectors of arboviruses. Furthermore, implementa-
tion of Wolbachia-based prevention strategies
should account for geographical specificities and
be accompanied by adequate public engagement
programmes to ensure community acceptance.
These strategies should also be adequately moni-
tored over a long period for timely detection of
potential adverse effects or changes in Wolbachia/
vector/virus interactions.
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